Chien et al. [7] also presented that PP2A, protein phosphatase 2 catalytic subunit alpha, a tumor suppressor protein, might be a possible target in pancreatic cancer, and reported that activating this gene together with administration of the drug Penfluridol increased sensitivity of pancreatic cancer cells to this treatment. Here, TCHP is linked to pancreatic neoplasm.